Progression-free survival, overall survival and immunophenotyping outcomes for patients with stage III-IV head and neck cancer and cisplatin contraindication treated with definitive radiotherapy plus pembrolizumab
| Autor: | J. Weiss, B. Vincent, A. Deal, J. Grilley-Olson, S. Patel, T. Hackman, J. Blumberg, T.J. Galloway, A. Zanation, C. Shen, D.N. Hayes, C. Hilliard, R. Mehra, K. McKinnon, H.H. Wang, M. Weissler, J. Bauman, S. Sheth, B.S. Chera |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
Cisplatin Cancer Research medicine.medical_specialty Radiation business.industry Head and neck cancer Pembrolizumab medicine.disease Immunophenotyping Internal medicine Medicine Radiology Nuclear Medicine and imaging Progression-free survival Stage (cooking) business Definitive radiotherapy Contraindication medicine.drug |
| Zdroj: | International Journal of Radiation Oncology*Biology*Physics. 106:1221 |
| ISSN: | 0360-3016 |
| DOI: | 10.1016/j.ijrobp.2020.02.003 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|